Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | FABP4 | P15090 | 4/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14781529 | 0.89 | FOLH1 (0.35) | FOLH1ALDH1A1 | |
| SCHEMBL1714540 | 0.87 | CASP6 (0.36) | ALDH1A1TBXA2RPKMP2RX3MAPK1 | |
| SCHEMBL17119895 | 0.86 | MEN1 (0.33) | ALDH1A1TBXA2RFABP4PKMP2RX3 | |
| SCHEMBL133416 | 0.85 | FOLH1 (0.32) | FOLH1 | |
| SCHEMBL9929222 | 0.85 | FOLH1 (0.32) | FOLH1 | |
| SCHEMBL14093814 | 0.84 | — | — | |
| SCHEMBL17483223 | 0.80 | DYRK1A (0.33) | ALDH1A1 | |
| SCHEMBL881201 | 0.80 | ALDH1A1 (0.35) | ALDH1A1TBXA2RFABP4PKMP2RX3 | |
| Potassium Ion SCHEMBL4886117 | 0.80 | FOLH1 (0.35) | FOLH1 | |
| SCHEMBL13264906 | 0.79 | CYP26B1 (0.35) | ALDH1A1TBXA2RFABP4PKMP2RX3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150268246-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC | 2015-09-24 | — | — | US | disclosed |
| US-8044203-B2 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | CARNEGIE MELLON UNIVERSITY (US) | 2011-10-25 | — | — | US | disclosed |
| US-8044203-B2 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | CARNEGIE MELLON UNIVERSITY (US) | 2011-10-25 | — | — | US | disclosed |
| EP-1525265-B1 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | UNIV CARNEGIE MELLON (US) | 2011-07-20 | — | — | EP | disclosed |
| EP-1525265-B1 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | UNIV CARNEGIE MELLON (US) | 2011-07-20 | — | — | EP | disclosed |
| US-20100267008-A1 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | CARNEGIE MELLON UNIVERSITY (US) | 2010-10-21 | — | — | US | disclosed |
| US-20100267008-A1 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | CARNEGIE MELLON UNIVERSITY (US) | 2010-10-21 | — | — | US | disclosed |
| US-7615646-B2 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | CARNEGIE MELLON UNIVERSITY (US) | 2009-11-10 | — | — | US | disclosed |
| US-7615646-B2 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | CARNEGIE MELLON UNIVERSITY (US) | 2009-11-10 | — | — | US | disclosed |
| US-7615646-B2 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | CARNEGIE MELLON UNIVERSITY (US) | 2009-11-10 | — | — | US | disclosed |
| US-20080076188-A1 | Luminescent compounds | SETA BIOMEDICALS, LLC | 2008-03-27 | — | — | US | disclosed |
| US-20060051758-A1 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060051758-A1 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | IDO1, TDO2, IDO2 | FOLH1 4593/4885ALDH1A1 1689/4885TBXA2R 4533/4885 |
| US-20100267008-A1 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | IDO1, IDO2, INMT | FOLH1 4440/4885ALDH1A1 1629/4885TBXA2R 4658/4885 |
| US-20080076188-A1 | Luminescent compounds | REL, QRFPR, RCOR3 | FOLH1 3522/4885ALDH1A1 1024/4885TBXA2R 974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.